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Figures
The worst mistake in this article was the printing of the wrong Figures 1 and 4 . The correct Figures appear here.
Tables
In Table 3 , the heading 'Colorectal cancer' should have been Human colorectal cancer, and the heading 'Liver' should have been Liver cancer. The same applies to Table 4 .
The investigations in reference 62, as reported in 
Cervix cancer.
In the footnotes to Table 8 , '5-fluoro-2'-deoxy cytidine' must be replaced by 5-fluoro-2'-deoxyuridine.
In Table 1 In Table 14 , footnote t, the dosage is just in U. In the right-hand column of page 89, line 6 from the bottom should have mentioned "Colon 26 9 Figure 4 Structural formulas of 5, A), The last sentence on page 92 should be: "A dosedependent increase of pyrimidine nucleoside phosphorylase activity was caused by interferon-~ [79]; uridine phosphorylase activity also increased after interferon~a [90] ."
CH -THF
quinazolin-9-yl) methyl]-N-methyl}-amino)-2-isoindolinyl]-L-glutamic acid (1843 U89; B), N 7 ~ 8-dideazafolic acid (CB3717; C), N-[4-(N-morph inosulphonyl)benzyl]-N-methyl-2, 6-diaminobenz[cd]indole glucuronate (A G 331; D), N-{5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl}-L-glutamic acid (D 1694; E) and 3,4-dihydro-2-amino-6-methyl-4-oxo-5 -(4-pyridylthio)quinazoline dihydrochloride (AG337; F)
On page 94, left-hand column, line 12-13 should have read "... could not be modulated by interferona [43] ." The last sentence of the left-hand column should read "The number of cell lines for which interferon-fl acts...".
On page 98, line 13-14 from the bottom should read "... allow the cell to grow and divide [110] ."
On page 100 the last sentence of the first paragraph should be changed to: "ICI D1694 (Tomudex) has been evaluated in several phase I trials [131] Tables 1 and 2 
